Enzymatic Extraction Reagent for Strep A Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunoassays for detecting Streptococcus pyogenes (Strep A) often suffer from high false positive rates due to molecular mimicry between Strep A antigens and human epithelial cell wall components, leading to incorrect binding of antibodies and inaccurate results.
Innovation Solution
An enzymatic extraction method using bacteriophage lysin PlyC or its derivatives is employed to release Strep A antigens from bacterial cells, allowing for more efficient and sensitive detection by neutral pH conditions that enhance antigen extraction and antibody interaction, while incorporating blocking reagents like N-acetyl-D-glucosamine to reduce false positives.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chemical extraction methods are used to release Strep A antigens, then antigen release is achieved, but false positive rates increase due to molecular mimicry between Strep A antigens and human epithelial cell wall components
Solution Approach 1:
The patent changes the extraction method from chemical to enzymatic (using PlyC bacteriophage lysin), which selectively degrades peptidoglycan in Strep A cell walls without affecting human epithelial cell wall components. This parameter change in extraction mechanism resolves the molecular mimicry issue by targeting bacterial-specific structures, thereby reducing false positives while maintaining antigen release efficiency.
2Reliability
If blocking reagents are added to reduce false positives, then specificity improves, but device complexity and assay steps increase
Solution Approach 1:
The patent extracts and removes the source of the problem (bacterial cell wall components causing false positives) by using PlyC enzymatic extraction. This eliminates the need for additional blocking reagents that would otherwise be required to prevent false positive binding, thereby maintaining high specificity while avoiding increased device complexity.
Solution Approach 2:
The enzymatic extraction with PlyC is performed as a preliminary step before the immunoassay, pre-cleaning the sample by selectively degrading bacterial cell walls and releasing antigens. This preliminary action prevents false positive interactions before they can occur during the assay, eliminating the need for subsequent blocking steps.
3Productivity
If pH is adjusted to enhance antigen extraction, then extraction efficiency improves, but additional processing steps and time are required
Solution Approach 1:
The patent replaces mechanical/chemical extraction methods (which require pH adjustment and extensive processing) with an enzymatic system (PlyC bacteriophage lysin). The enzyme naturally optimizes its activity conditions and selectively degrades peptidoglycan at physiological pH, eliminating the need for additional pH adjustment steps and reducing overall processing time while maintaining high extraction efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The enzymatic extraction method improves the specificity and sensitivity of Strep A detection, reducing false positive rates and enabling more accurate identification of Strep A antigens in biological samples without the need for additional blocking agents in the assay device.
Implementation Method 1
The extraction reagent comprises a bacteriophage lysin, PlyC or a derivative of PlyC, wherein PlyC is capable of degrading a cell wall of the Strep A bacterium
Implementation Method 2
PlyC is a bacteriophage-encoded, multimeric lysin composed of two distinct gene products, PlyCA and PlyCB. A single PlyCA protein binds to the octamer PlyCB to form the functional holoenzyme of PlyC. The PlyCA molecule is responsible for the enzymatic activity
Data Source
AI summary
An enzymatic extraction agent, as well as methods, compositions and kits for detecting Group A streptococcus in a biological sample, which involve the enzymatic agent, are described.